Sci Total Environ:长期PM2.5和CO暴露会增加CKD患者的死亡率

2021-05-12 Nebula MedSci原创

长期暴露于空气污染对CKD患者的死亡率具有负面影响,CKD患者可尽量避免空气污染暴露以改善预后

据世界卫生组织(WHO)报告,全球约23%(1260万例)的死亡病例与环境因素有密切相关性。大气空气动力学直径小于2.5 μm的细颗粒物(PM2.5)每年约造成900万人死亡。由于PM2.5只是细颗粒物的尺寸分类,其生化特性因暴露源的多样性和不确定性而难以明确。

在全球工业化持续高速发展的情况下,与空气污染有关的疾病负担也正在与日俱增。虽然,普通人群与空气污染相关的风险已得到了充分的调研,但很少有研究聚焦于空气污染暴露对东亚慢性肾脏病(CKD)患者临床预后的影响。

本研究目的是在东亚CKD患者中评估空气污染暴露对其临床预后的影响

研究人员对参与在韩国首尔3个医疗中心开展的一个回顾性队列招募的29602位CKD患者进行分析,采用距离反比加权法(IDW)评估了CKD患者的死亡率与五种空气污染物(PM2.5、PM10、NO2、SO2和CO)的个体暴露水平之间的相关性,并根据性别、年龄、eGFR、血红蛋白、高血压、糖尿病和区域特征进行校正。

在随访6.14±3.96年期间,共记录了3865例死亡(13%),其中大部分是女性(53%),基线时的平均年龄为58±17岁。

不同污染物暴露与CKD死亡率的相关性

经分析证实,PM2.5和CO暴露显著影响CKD患者的死亡率(风险比[HR]分别是1.17,95%CI 1.07-0.29 和 1.17,95%CI 1.00-1.38);而PM10、NO2和SO2暴露与CKD患者的死亡率均无明显相关性。

根据年龄、体重指数、吸烟和饮酒状况进行分层后的相关性

根据年龄、体重指数、吸烟和饮酒状况进行分层时,空气污染暴露与CKD患者死亡率的相关性会部分随之相应变化,该相关性在65岁以上、瘦弱和不饮酒的患者中最为明显

总而言之,长期暴露于空气污染对CKD患者的死亡率具有负面影响,CKD患者可尽量避免空气污染暴露以改善预后

原始出处:

Jung Jiyun,Park Jae Yoon,Kim Yong Chul et al. Effects of air pollution on mortality of patients with chronic kidney disease: A large observational cohort study. Sci Total Environ, 2021, 786: 147471. https://doi.org/10.1016/j.scitotenv.2021.147471

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1768856, encodeId=fdb71e68856e6, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4796, encryptionId=51cd4e9650, topicName=CKD患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fa237912269, createdName=12498f17m78暂无昵称, createdTime=Wed Dec 15 12:27:45 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795795, encodeId=9e841e95795f7, content=<a href='/topic/show?id=1c811e6768a' target=_blank style='color:#2F92EE;'>#Total#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17676, encryptionId=1c811e6768a, topicName=Total)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Tue Nov 23 21:27:45 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265029, encodeId=12fb1265029f9, content=<a href='/topic/show?id=9574144034a' target=_blank style='color:#2F92EE;'>#PM2.5#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14403, encryptionId=9574144034a, topicName=PM2.5)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524318, encodeId=3bf015243180d, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965085, encodeId=476796508598, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/945056a487d64cd5b2a3e2368b8393c8/097ea7aeba85402bb163f8b5a1fd4054.jpg, createdBy=d6575500024, createdName=kk同学923, createdTime=Thu May 13 03:06:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964979, encodeId=6afd9649e96f, content=好~, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5478833, createdName=ms5000000790714074, createdTime=Wed May 12 19:39:09 CST 2021, time=2021-05-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1768856, encodeId=fdb71e68856e6, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4796, encryptionId=51cd4e9650, topicName=CKD患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fa237912269, createdName=12498f17m78暂无昵称, createdTime=Wed Dec 15 12:27:45 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795795, encodeId=9e841e95795f7, content=<a href='/topic/show?id=1c811e6768a' target=_blank style='color:#2F92EE;'>#Total#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17676, encryptionId=1c811e6768a, topicName=Total)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Tue Nov 23 21:27:45 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265029, encodeId=12fb1265029f9, content=<a href='/topic/show?id=9574144034a' target=_blank style='color:#2F92EE;'>#PM2.5#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14403, encryptionId=9574144034a, topicName=PM2.5)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524318, encodeId=3bf015243180d, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965085, encodeId=476796508598, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/945056a487d64cd5b2a3e2368b8393c8/097ea7aeba85402bb163f8b5a1fd4054.jpg, createdBy=d6575500024, createdName=kk同学923, createdTime=Thu May 13 03:06:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964979, encodeId=6afd9649e96f, content=好~, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5478833, createdName=ms5000000790714074, createdTime=Wed May 12 19:39:09 CST 2021, time=2021-05-12, status=1, ipAttribution=)]
    2021-11-23 xugc
  3. [GetPortalCommentsPageByObjectIdResponse(id=1768856, encodeId=fdb71e68856e6, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4796, encryptionId=51cd4e9650, topicName=CKD患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fa237912269, createdName=12498f17m78暂无昵称, createdTime=Wed Dec 15 12:27:45 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795795, encodeId=9e841e95795f7, content=<a href='/topic/show?id=1c811e6768a' target=_blank style='color:#2F92EE;'>#Total#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17676, encryptionId=1c811e6768a, topicName=Total)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Tue Nov 23 21:27:45 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265029, encodeId=12fb1265029f9, content=<a href='/topic/show?id=9574144034a' target=_blank style='color:#2F92EE;'>#PM2.5#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14403, encryptionId=9574144034a, topicName=PM2.5)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524318, encodeId=3bf015243180d, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965085, encodeId=476796508598, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/945056a487d64cd5b2a3e2368b8393c8/097ea7aeba85402bb163f8b5a1fd4054.jpg, createdBy=d6575500024, createdName=kk同学923, createdTime=Thu May 13 03:06:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964979, encodeId=6afd9649e96f, content=好~, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5478833, createdName=ms5000000790714074, createdTime=Wed May 12 19:39:09 CST 2021, time=2021-05-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1768856, encodeId=fdb71e68856e6, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4796, encryptionId=51cd4e9650, topicName=CKD患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fa237912269, createdName=12498f17m78暂无昵称, createdTime=Wed Dec 15 12:27:45 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795795, encodeId=9e841e95795f7, content=<a href='/topic/show?id=1c811e6768a' target=_blank style='color:#2F92EE;'>#Total#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17676, encryptionId=1c811e6768a, topicName=Total)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Tue Nov 23 21:27:45 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265029, encodeId=12fb1265029f9, content=<a href='/topic/show?id=9574144034a' target=_blank style='color:#2F92EE;'>#PM2.5#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14403, encryptionId=9574144034a, topicName=PM2.5)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524318, encodeId=3bf015243180d, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965085, encodeId=476796508598, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/945056a487d64cd5b2a3e2368b8393c8/097ea7aeba85402bb163f8b5a1fd4054.jpg, createdBy=d6575500024, createdName=kk同学923, createdTime=Thu May 13 03:06:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964979, encodeId=6afd9649e96f, content=好~, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5478833, createdName=ms5000000790714074, createdTime=Wed May 12 19:39:09 CST 2021, time=2021-05-12, status=1, ipAttribution=)]
    2021-05-14 july_979
  5. [GetPortalCommentsPageByObjectIdResponse(id=1768856, encodeId=fdb71e68856e6, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4796, encryptionId=51cd4e9650, topicName=CKD患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fa237912269, createdName=12498f17m78暂无昵称, createdTime=Wed Dec 15 12:27:45 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795795, encodeId=9e841e95795f7, content=<a href='/topic/show?id=1c811e6768a' target=_blank style='color:#2F92EE;'>#Total#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17676, encryptionId=1c811e6768a, topicName=Total)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Tue Nov 23 21:27:45 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265029, encodeId=12fb1265029f9, content=<a href='/topic/show?id=9574144034a' target=_blank style='color:#2F92EE;'>#PM2.5#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14403, encryptionId=9574144034a, topicName=PM2.5)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524318, encodeId=3bf015243180d, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965085, encodeId=476796508598, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/945056a487d64cd5b2a3e2368b8393c8/097ea7aeba85402bb163f8b5a1fd4054.jpg, createdBy=d6575500024, createdName=kk同学923, createdTime=Thu May 13 03:06:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964979, encodeId=6afd9649e96f, content=好~, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5478833, createdName=ms5000000790714074, createdTime=Wed May 12 19:39:09 CST 2021, time=2021-05-12, status=1, ipAttribution=)]
    2021-05-13 kk同学923

    👍👍👍

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1768856, encodeId=fdb71e68856e6, content=<a href='/topic/show?id=51cd4e9650' target=_blank style='color:#2F92EE;'>#CKD患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4796, encryptionId=51cd4e9650, topicName=CKD患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fa237912269, createdName=12498f17m78暂无昵称, createdTime=Wed Dec 15 12:27:45 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795795, encodeId=9e841e95795f7, content=<a href='/topic/show?id=1c811e6768a' target=_blank style='color:#2F92EE;'>#Total#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17676, encryptionId=1c811e6768a, topicName=Total)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e1c493, createdName=xugc, createdTime=Tue Nov 23 21:27:45 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265029, encodeId=12fb1265029f9, content=<a href='/topic/show?id=9574144034a' target=_blank style='color:#2F92EE;'>#PM2.5#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14403, encryptionId=9574144034a, topicName=PM2.5)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87f580, createdName=yilong5287542, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524318, encodeId=3bf015243180d, content=<a href='/topic/show?id=053710045ad' target=_blank style='color:#2F92EE;'>#iron#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10045, encryptionId=053710045ad, topicName=iron)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1b11597510, createdName=july_979, createdTime=Fri May 14 10:27:45 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965085, encodeId=476796508598, content=👍👍👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210513/945056a487d64cd5b2a3e2368b8393c8/097ea7aeba85402bb163f8b5a1fd4054.jpg, createdBy=d6575500024, createdName=kk同学923, createdTime=Thu May 13 03:06:27 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964979, encodeId=6afd9649e96f, content=好~, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e3a5478833, createdName=ms5000000790714074, createdTime=Wed May 12 19:39:09 CST 2021, time=2021-05-12, status=1, ipAttribution=)]
    2021-05-12 ms5000000790714074

    好~

    0

相关资讯

Neurology:当心空气污染,晚年暴露于PM2.5 痴呆风险明显增加

当心空气污染:晚年暴露于PM2.5 痴呆风险明显增加

JAHA:长期暴露于空气污染与心衰患者30天再入院率和就诊次数相关

鉴于心力衰竭患者的住院和再入院率较高,这些结果也是对可改善的环境危险因素的重要见解,这些因素可改善心衰患者的预后并减少医院资源使用。

沙尘暴来袭!北京空气质量已达严重污染

今天,北京市气象台升级发布沙尘暴黄色预警信号。据北京市生态环境监测中心网站消息,截至15日7时,北京市空气质量指数为500,污染级别为6级,已达严重污染标准。

JAHA:环境空气污染对儿童和青少年血压的影响

短期和长期接触某些环境空气污染物可能会升高儿童和青少年的BP。